Clinical Trial Update: LACTIN-V Study for Recurrent Bacterial Vaginosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of LACTIN-V for recurrent bacterial vaginosis completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Lactin-V (Lactobacillus crispatus CTV-05)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Vaginosis | Phase 2 | Status: COMPLETED | Results posted: 2020-02-11